Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News InVivo Therapeutics Holdings Corp NVIVQ

Healthcare Medical Devices
InVivo Therapeutics Holdings Corp. is a research and clinical-stage biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries (SCIs). The Company's Neuro-Spinal Scaffold implant is an investigational bioresorbable polymer scaffold that is designed for implantation at the site of injury within a spinal cord. It is intended to promote appositional, or side-by... see more

Recent & Breaking News (OTCPK:NVIVQ)

InVivo Therapeutics Announces Enrollment of Second Subject in Pilot Spinal Cord Injury Trial

Business Wire January 22, 2015

InVivo Therapeutics Reports Three-Month Update of First Acute Spinal Cord Injury Subject Implanted with Neuro-Spinal Scaffold

Business Wire January 21, 2015

InVivo Therapeutics Announces Reopening of Enrollment for Ongoing Pilot Trial

Business Wire January 9, 2015

InVivo Therapeutics Announces FDA Approval to Expedite Enrollment for Ongoing Pilot Trial

Business Wire December 16, 2014

InVivo Therapeutics Announces University of Pittsburgh Medical Center Presbyterian as New Clinical Trial Site for Neuro-Spinal Scaffold

Business Wire November 25, 2014

InVivo Therapeutics Announces Oregon Health & Science University as Fifth Clinical Trial Site for Neuro-Spinal Scaffold

Business Wire November 21, 2014

Medical Device Makers Are Cheering After Latest Victory from GOP

Accesswire November 14, 2014

InVivo Therapeutics Announces Appointment of Ann Merrifield to Its Board of Directors

Business Wire November 11, 2014

InVivo Therapeutics Reports 2014 Third Quarter Financial Results and Business Update

Business Wire November 5, 2014

InVivo Therapeutics Receives FDA Approval to Broaden Inclusion Criteria and Add 14 Additional Sites (20 Total) for Ongoing Pilot Trial

Business Wire October 29, 2014

InVivo Therapeutics Announces Barnes-Jewish Hospital at Washington University as New Clinical Trial Site for Neuro-Spinal Scaffold

Business Wire October 20, 2014

InVivo Therapeutics Announces First Subject Enrolled in Pilot Spinal Cord Injury Trial

Business Wire October 15, 2014

InVivo Therapeutics to Exhibit at 2014 Congress of Neurological Surgeons Annual Meeting

Business Wire October 6, 2014

Deadline Monday: Levi & Korsinsky, LLP Reminds Investors of Class Action Against InVivo Therapeutics Holdings Corp. and Its Board of Directors and a Lead Plaintiff Deadline of October 6, 2014

Business Wire October 3, 2014

UPCOMING DEADLINE ALERT: Brower Piven Encourages Investors Who Have Losses in Excess of $100,000 From Investment in InVivo Therapeutics Holdings Corp. to Contact the Firm Before the October 6, 2014 Lead Plaintiff Deadline in Class Action Lawsuit -- NVIV

GlobeNewswire October 2, 2014

UPCOMING DEADLINE: Levi & Korsinsky, LLP Reminds Investors of Class Action Against InVivo Therapeutics Holdings Corp. and Its Board of Directors and a Lead Plaintiff Deadline of October 6, 2014 -- NVIV

PR Newswire September 29, 2014

InVivo Therapeutics Announces Appointment of Daniel R. Marshak, PhD to Its Board of Directors

Business Wire September 29, 2014

EQUITY ALERT: Rosen Law Firm Reminds InVivo Therapeutics Holdings Corp. Investors of Important October 6, 2014 Class Action Deadline -- NVIV

GlobeNewswire September 26, 2014

UPCOMING DEADLINE: The Law Offices of Vincent Wong Remind Investors of Class Action Involving InVivo Therapeutics Holdings Corp. and a Lead Plaintiff Deadline of October 6, 2014 -- NVIV

GlobeNewswire September 17, 2014

SHAREHOLDER ALERT: Brower Piven Encourages Investors Who Have Losses In Excess Of $100,000 From Investment In InVivo Therapeutics Holdings Corp. To Contact The Firm Before The October 6, 2014 Lead Plaintiff Deadline In Class Action Lawsuit

Business Wire September 17, 2014